natgillin/translations-raw huggingface dataset:
A meta-analysis including nine trials in patients with type 1 and type 2 diabetes showed that fasting blood glucose was higher in patients treated with NovoMix 30, than in patients treated with biphasic human insulin 30. 
Metaanaliza, ki je zajela devet preskušanj pri bolnikih s sladkorno boleznijo tipa 1 in tipa 2, je pokazala, da je bila glukoza v krvi na tešče višja pri bolnikih, ki so dobivali zdravilo NovoMix 30, kot pri bolnikih, ki so dobivali dvofazni humani insulin 30.
► Do not refill your FlexPen. 
► Injekcijskega peresnika FlexPen ne smete znova polniti.
With each injection, change the injection site within the particular area of skin that you use. 
Mesto injiciranja na posameznem predelu kože, ki ga uporabljate, menjajte pri vsakem injiciranju.
Do not use this medicinal product if you notice that the resuspended liquid is not uniformly white, cloudy and aqueous. 
Zdravila ne uporabite, če opazite, da resuspendirana tekočina ni enakomerno bela, motna in vodna.
The safety and efficacy of NovoMix 50 in children below 18 years of age have not been established. 
Varnost in učinkovitost zdravila NovoMix 50 nista ugotovljeni pri otrocih, mlajših od 18 let.
Do not use this medicine after the expiry date, which is stated on the cartridge label and carton after ‘EXP'. 
Tega zdravila ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na nalepki vložka in škatli poleg oznake ‘Uporabno do'.
The advisability of driving or operating a machine should be considered in these circumstances. 
V takšnih okoliščinah je treba pretehtati, ali je priporočljivo, da bolnik vozi ali upravlja s stroji.
After resuspension, the liquid should appear uniformly white, cloudy and aqueous. 
Po resuspendiranju mora biti tekočina enakomerno bela, motna in vodna.
+2 units 
+ 2 enoti
The safety and efficacy of NovoMix 70 in children below 18 years of age have not been established. 
Varnost in učinkovitost zdravila NovoMix 70 nista ugotovljeni pri otrocih, mlajših od 18 let.
Non-clinical data reveal no special hazard for humans based on conventional studies of safety pharmacology, repeated dose toxicity, genotoxicity and toxicity to reproduction and development. 
Neklinični podatki na osnovi običajnih študij farmakološke varnosti, toksičnosti pri ponavljajočih se odmerkih, genotoksičnosti, vpliva na sposobnost razmnoževanja in razvoja ne kažejo posebnega tveganja za človeka.
Uncommon - Oedema 
Občasno - edemi
If the moving procedure alone is not enough to give a uniformly white, cloudy and aqueous liquid, repeat the rolling and moving procedures (see B and C) until the liquid does appear uniformly white, cloudy and aqueous. 
Če s tem postopkom ne dobite enakomerno bele, motne in vodne tekočine, ga ponavljajte (glejte B in C), dokler ni tekočina enakomerno bela, motna in vodna.
+4 units 
+ 4 enote
Move the pen up and down between the two positions at least 10 times until the liquid does appear uniformly white, cloudy and aqueous. 
Obrnite injekcijski peresnik z vložkom vsaj 10-krat gor in dol med obema položajema, dokler ni tekočina enakomerno bela, motna in vodna.
• There is limited experience with NovoMix 30 in children aged 6-9 years. 
• Izkušnje z uporabo zdravila NovoMix 30 pri otrocih, starih od 6 do 9 let, so omejene.
NovoMix 30 can be used in adolescents and children aged 10 years and above when premixed insulin is preferred. 
Zdravilo NovoMix 30 je mogoče uporabiti pri mladostnikih in otrocih, starih 10 let in več, kadar ima v terapiji prednost uporaba mešanega insulina.
NovoMix 50 which has been frozen must not be used. 
Zdravila NovoMix 50, ki je bil zamrznjen, se ne sme uporabiti.
During clinical trials, the overall rates of hypoglycaemia did not differ between patients treated with insulin aspart compared to human insulin. 
V kliničnih preskušanjih ni bilo razlik med celotnim deležem hipoglikemij pri bolnikih, zdravljenih z insulinom aspart, in bolnikih, ki so dobivali humani insulin.
NovoMix 70 may fully or partially meet this requirement. 
Zdravilo NovoMix 70 lahko to potrebo pokrije v celoti ali delno.
In patients with type 2 diabetes, a dose reduction of 20% is recommended for patients with an HbA1c less than 8% when a GLP-1 receptor agonist is added to NovoMix 30, to minimise the risk of hypoglycaemia. 
Pri bolnikih s sladkorno boleznijo tipa 2 in vrednostjo HbA1c manj kot 8 %, ki se jim pri zdravljenju z zdravilom NovoMix 30 dodatno uvede agonist receptorjev GLP-1, je priporočljivo odmerek zdravila
At the beginning of the insulin treatment, refraction anomalies, oedema and injection site reactions (pain, redness, hives, inflammation, bruising, swelling and itching at the injection site) may occur. 
Na začetku zdravljenja z insulinom se lahko pojavijo refrakcijske anomalije, edemi in reakcije na mestu injiciranja (bolečina, pordelost, koprivnica, vnetje, podplutba, oteklina in srbenje na mestu injiciranja).
NovoMix 70 which has been frozen must not be used. 
Zdravila NovoMix 70, ki je bil zamrznjen, se ne sme uporabiti.
LIST OF EXCIPIENTS glycerol, phenol, metacresol, zinc chloride, disodium phosphate dihydrate, sodium chloride, protamine sulfate, hydrochloric acid/sodium hydroxide for pH adjustment and water for injections 
SEZNAM POMOŽNIH SNOVI glicerol, fenol, metakrezol, cinkov klorid, natrijev hidrogenfosfat dihidrat, natrijev klorid, protaminijev sulfat, klorovodikovo kislino/natrijev hidroksid za uravnavanje pH in vodo za injekcije.
NovoMix 70 may be used in combination with metformin. 
Zdravilo NovoMix 70 se lahko uporablja v kombinaciji z metforminom.
Resuspending your insulin 
Resuspendiranje insulina
Each cartridge contains 300 units of insulin aspart in 3 ml suspension for injection. 
En vložek vsebuje 300 enot insulina aspart v 3 ml suspenzije za injiciranje.
+6 units 
+ 6 enot
Transfer to NovoMix 70 from other insulin preparations may require adjustment of dose and timing of administration. 
Pri prehodu na zdravilo NovoMix 70 z drugih insulinskih zdravil bo morda potrebno prilagoditi odmerek in čas apliciranja.
Each pre-filled pen contains 300 units of insulin aspart in 3 ml suspension for injection. 
En napolnjen injekcijski peresnik vsebuje 300 enot insulina aspart v 3 ml suspenzije za injiciranje.
NovoMix 30 Penfill EU/1/00/142/004 EU/1/00/142/005 
NovoMix 30 Penfill EU/1/00/142/004
NovoMix 30 which has been frozen must not be used. 
Zdravila NovoMix 30, ki je bil zamrznjen, se ne sme uporabiti.
NovoMix 50 is indicated for treatment of diabetes mellitus in adults. 
Zdravilo NovoMix 50 je namenjeno zdravljenju sladkorne bolezni pri odraslih.
When transferring a patient from biphasic human insulin to NovoMix 30, start with the same dose and regimen. 
Ko bolnik preide z dvofaznega humanega insulina na zdravilo NovoMix 30, morate zdravilo NovoMix 30 uvesti v enakem odmerku in po enaki shemi.
When NovoMix 70 is used in combination with metformin the dose should be adjusted. 
Kadar zdravilo NovoMix 70 uporabljate v kombinaciji z metforminom, mora biti odmerek prilagojen.
Continuous rotation of the injection site within the particular area reduces the risk of developing these reactions. 
Stalno krožno menjavanje mest injiciranja na posameznem predelu zmanjša tveganje za nastanek teh reakcij.
If you have any further questions on the use of this medicine, ask your doctor, nurse or pharmacist. 
Če imate dodatna vprašanja o uporabi zdravila, se posvetujte s svojim zdravnikom, z medicinsko sestro ali s farmacevtom.
When NovoMix 50 is used in combination with metformin the dose should be adjusted. 
Kadar zdravilo NovoMix 50 uporabljate v kombinaciji z metforminom, mora biti odmerek prilagojen.
In patients with type 2 diabetes, NovoMix 70 can be given as monotherapy or in combination with metformin when the blood glucose is inadequately controlled with metformin alone. 
Pri bolnikih s sladkorno boleznijo tipa 2 lahko zdravilo NovoMix 70 uporabite kot monoterapijo ali v kombinaciji z metforminom, če glukoza v krvi s samim metforminom ni zadostno urejena.
They include: increased urination; feeling thirsty; losing your appetite; feeling sick (nausea or vomiting); feeling drowsy or tired; flushed; dry skin; dry mouth and a fruity (acetone) smell of the breath. 
Med njimi so: pogostejše uriniranje, občutek žeje, izguba apetita, občutek slabosti (siljenje na bruhanje ali bruhanje), občutek zaspanosti ali utrujenosti, pordela in suha koža, suha usta in sadni (acetonski) zadah izdihanega zraka.
NovoMix 50 must be protected from excessive heat and light. 
Zdravilo NovoMix 50 je treba zaščititi pred čezmerno toploto in svetlobo.
• Repeat the rolling and moving procedures (see pictures A and B) until the liquid appears uniformly white, cloudy and aqueous. 
• Ponavljajte postopek vrtenja in obračanja (glejte sliki A in B), dokler ni tekočina enakomerno bela, motna in vodna.
NovoMix 70 must be protected from excessive heat and light. 
Zdravilo NovoMix 70 je treba zaščititi pred čezmerno toploto in svetlobo.
The following substances may reduce the patient's insulin requirements: Oral antidiabetic medicinal products, GLP-1 receptor agonists, monoamine oxidase inhibitors (MAOI), beta-blockers, angiotensin converting enzyme (ACE) inhibitors, salicylates, anabolic steroids and sulfonamides. 
Bolnikovo potrebo po insulinu lahko zmanjšajo naslednje snovi: peroralni antidiabetiki, agonisti receptorjev GLP-1, zaviralci monoaminooksidaze (MAO), zaviralci adrenergičnih receptorjev beta, zaviralci encima angiotenzinske konvertaze (ACE), salicilati, anabolni steroidi in sulfonamidi.
Mean HbA1c remained similar to baseline throughout the trial in both treatment groups, and there was no difference in hypoglycaemia rate with NovoMix 30 or biphasic human insulin 30. 
Povprečni HbA1c je ostal v obeh terapevtskih skupinah ves čas preskušanja podoben izhodiščnemu; delež hipoglikemij se med uporabo zdravila NovoMix 30 ali bifaznega humanega insulina 30 ni razlikoval.
What NovoMix 70 is and what it is used for 
Kaj je zdravilo NovoMix 70 in za kaj ga uporabljamo
NovoMix 70 must not be administered intravenously, as it may result in severe hypoglycaemia. 
Zdravila NovoMix 70 se ne sme aplicirati intravensko, ker lahko povzroči hudo hipoglikemijo.
• If you have any further questions, ask your doctor, nurse or pharmacist. 
• Če imate dodatna vprašanja, se posvetujte z zdravnikom, medicinsko sestro ali s farmacevtom.
NovoMix 30 must not be administered intravenously, as it may result in severe hypoglycaemia. 
Zdravila NovoMix 30 se ne sme aplicirati intravensko, ker lahko povzroči hudo hipoglikemijo.
► Always make sure that you have resuspended the insulin prior to each injection. 
► Pred vsakim injiciranjem morate insulin resuspendirati.
3 ml suspension in cartridge (type 1 glass) with a plunger (bromobutyl) and a rubber closure (bromobutyl/polyisoprene). 
3 ml suspenzije v vložku (steklo tipa I) z batom (bromobutil) in gumijasto zaporko
NovoMix 30 must be protected from excessive heat and light. 
Zdravilo NovoMix 30 je treba zaščititi pred čezmerno toploto in svetlobo.
Figure 1: Activity Profile for NovoMix 70 in Healthy Caucasian Subjects. 
Slika 1: Profil delovanja zdravila NovoMix 70 pri zdravih belcih
If you take too much insulin, your blood sugar gets too low (hypoglycaemia). 
Če ste si injicirali preveč insulina, se vam lahko krvni sladkor preveč zniža (hipoglikemija).
NovoMix 70 dosing is individual and determined in accordance with the needs of the patient. 
Odmerjanje zdravila NovoMix 70 je individualno in določeno v skladu z bolnikovimi potrebami.
Insulins and analogues for injection, intermediate- or long-acting combined with fast-acting. 
Farmakoterapevtska skupina: zdravila za zdravljenje sladkorne bolezni, insulini in analogi za injiciranje s srednjedolgim ali dolgotrajnim delovanjem s takojšnjim učinkom.
NovoMix 50 may be used in combination with metformin. 
Zdravilo NovoMix 50 se lahko uporablja v kombinaciji z metforminom.
In patients with type 2 diabetes, NovoMix 50 can be given as monotherapy or in combination with metformin when the blood glucose is inadequately controlled with metformin alone. 
Pri bolnikih s sladkorno boleznijo tipa 2 lahko zdravilo NovoMix 50 uporabite kot monoterapijo ali v kombinaciji z metforminom, če glukoza v krvi s samim metforminom ni zadostno urejena.
• Let the insulin reach room temperature before you use it. 
• Preden uporabite vložek, ga pustite da doseže sobno temperaturo.
In elderly patients, glucose monitoring should be intensified and the insulin aspart dose adjusted on an individual basis. 
Pri starejših bolnikih je treba koncentracijo glukoze v krvi spremljati pozorneje ter odmerek insulina aspart prilagoditi posamezniku.
NovoMix 30 dosing is individual and determined in accordance with the needs of the patient. 
Odmerjanje zdravila NovoMix 30 je individualno in določeno v skladu z bolnikovimi potrebami.
There is limited clinical experience with NovoMix 30 in children aged 6-9 years (see section 5.1). 
do 9. leta starosti je kliničnih izkušenj malo (glejte poglavje 5.1).
NovoMix 30 may fully or partially meet this requirement. 
Zdravilo NovoMix 30 lahko to potrebo pokrije delno ali v celoti.
What NovoMix 50 is and what it is used for 
Kaj je zdravilo NovoMix 50 in za kaj ga uporabljamo
NovoMix 50 dosing is individual and determined in accordance with the needs of the patient. 
Odmerjanje zdravila NovoMix 50 je individualno in določeno v skladu z bolnikovimi potrebami.
Detailed information on this medicinal product is available on the website of the European Medicines Agency http://www.ema.europa.eu. 
Podrobne informacije o zdravilu so objavljene na spletni strani Evropske agencije za zdravila:
What NovoMix 70 is and what it is used for What you need to know before you use NovoMix 70 How to use NovoMix 70 
Kaj je zdravilo NovoMix 70 in za kaj ga uporabljamo Kaj morate vedeti, preden boste uporabili zdravilo NovoMix 70 Kako uporabljati zdravilo NovoMix 70
The following substances may reduce the patient's insulin requirements: Oral antidiabetic medicinal products, monoamine oxidase inhibitors (MAOI), beta-blockers, angiotensin converting enzyme (ACE) inhibitors, salicylates, anabolic steroids and sulfonamides. 
Bolnikovo potrebo po insulinu lahko zmanjšajo naslednje snovi: peroralni antidiabetiki, zaviralci monoaminooksidaze (MAO), zaviralci adrenergičnih receptorjev beta, zaviralci encima angiotenzinske konvertaze (ACE), salicilati, anabolni steroidi in sulfonamidi.
In patients with renal or hepatic impairment, glucose monitoring should be intensified and the insulin aspart dose adjusted on an individual basis. 
Pri bolnikih z ledvično ali jetrno okvaro je treba koncentracijo glukoze v krvi spremljati pozorneje ter odmerek insulina aspart prilagoditi posamezniku.
Pack sizes of 1 (with or without needles), 5 (without needles) and 10 (without needles) pre-filled pens of 3 ml. 
Pakiranja z 1 (z iglami ali brez), 5 (brez igel) in 10 (brez igel) napolnjenimi injekcijskimi peresniki po 3 ml. Na trgu morda ni vseh navedenih pakiranj.
The influence of different injection sites on the absorption of NovoMix 70 has not been investigated. 
Vpliv različnih mest injiciranja na absorpcijo zdravila NovoMix 70 ni raziskan.
In patients with type 2 diabetes, a meta-analysis showed a reduced risk of overall nocturnal hypoglycaemic episodes and major hypoglycaemia with NovoMix 30 compared to biphasic human insulin 30. 
Metaanaliza je pri bolnikih s sladkorno boleznijo tipa 2 pokazala manjše tveganje vseh nočnih hipoglikemij in hudih hipoglikemij med uporabo zdravila NovoMix 30 kot med uporabo dvofaznega humanega insulina 30.
In a 3 month trial in patients with type 1 and type 2 diabetes, NovoMix 30 showed equal control of glycosylated haemoglobin compared to treatment with biphasic human insulin 30. 
V 3-mesečnem preskušanju bolnikov s sladkorno boleznijo tipa 1 in tipa 2 je bila urejenost glikiranega hemoglobina z zdravilom NovoMix 30 enaka kot med zdravljenjem z dvofaznim humanim insulinom 30.
See Instructions for use. 
Navodilo za uporabo
Figure 1: Activity Profile for NovoMix 50 in Healthy Caucasian Subjects. 
Slika 1: Profil delovanja zdravila NovoMix 50 pri zdravih belcih
What NovoMix 50 is and what it is used for What you need to know before you use NovoMix 50 How to use NovoMix 50 
Kaj je zdravilo NovoMix 50 in za kaj ga uporabljamo Kaj morate vedeti, preden boste uporabili zdravilo NovoMix 50 Kako uporabljati zdravilo NovoMix 50
• Move the delivery system with the cartridge inside up and down between a and b (see picture B) at least 10 times until the liquid appears uniformly white, cloudy and aqueous. 
• Obrnite injekcijski peresnik z vložkom vsaj 10-krat gor in dol med položajema a in b (glejte sliko B), dokler ni tekočina enakomerno bela, motna in vodna.
If you have taken any of the medicines listed here, tell your doctor, nurse or pharmacist. 
Če ste vzeli katero koli zgoraj navedeno zdravilo, povejte to svojemu zdravniku, medicinski sestri ali farmacevtu.
Transfer to NovoMix 50 from other insulin preparations may require adjustment of dose and timing of administration. 
Pri prehodu na zdravilo NovoMix 50 z drugih insulinskih zdravil bo morda potrebno prilagoditi odmerek in čas apliciranja.
The suspension contains rapid-acting and intermediate-acting insulin aspart in the ratio 50/50. 
Suspenzija vsebuje hitrodelujoči in srednjedolgodelujoči insulin aspart v razmerju 50/50.
► If after resuspension, clumps of material are present or if solid white particles stick to the bottom or the wall of the cartridge. 
► če so v resuspendiranem insulinu vidne grude ali se dna ali stene vložka držijo trdni beli delci.
NovoMix 50 may fully or partially meet this requirement. 
Zdravilo NovoMix 50 lahko to potrebo pokrije v celoti ali delno.
NovoMix 70 is used to reduce the high blood sugar level in patients with diabetes mellitus (diabetes). 
Zdravilo NovoMix 70 se uporablja za znižanje visokega krvnega sladkorja pri bolnikih s sladkorno boleznijo.
Before using NovoMix 70 
Preden uporabite zdravilo NovoMix 70
NovoMix 50 is used to reduce the high blood sugar level in patients with diabetes mellitus (diabetes). 
Zdravilo NovoMix 50 se uporablja za znižanje visokega krvnega sladkorja pri bolnikih s sladkorno boleznijo.
Repeat rolling and moving the pen until the liquid does appear uniformly white, cloudy and aqueous. 
Ponavljajte postopek vrtenja in obračanja injekcijskega peresnika, dokler ni tekočina enakomerno bela, motna in vodna.
Pack sizes of 1, 5 and 10 cartridges. 
Pakiranja z 1, 5 in 10 vložki.
The influence of different injection sites on the absorption of NovoMix 50 has not been investigated. 
Vpliv različnih mest injiciranja na absorpcijo zdravila NovoMix 50 ni raziskan.
Glucose Infusion Rate 
Hitrost infundiranja glukoze
Close glucose monitoring is recommended during the transfer and in the initial weeks thereafter (see section 4.4). 
Pri prehodu z drugih insulinskih zdravil ter nekaj tednov po njem je priporočljivo skrbno spremljanje glukoze v krvi (glejte poglavje 4.4).
In type 1 patients with diabetes a mean maximum serum concentration of 721 ± 184 pmol/l was reached about 60 minutes after a subcutaneous dose of 0.30 unit/kg body weight. 
Pri bolnikih s sladkorno boleznijo tipa 1 je bila povprečna največja koncentracija v serumu 721 ± 184 pmol/l dosežena okrog 60 minut po subkutanem odmerku 0,30 enote/kg telesne mase.
NovoMix 70 is generally taken immediately before a meal. 
Zdravilo NovoMix 70 se praviloma uporabi tik pred obrokom.
Attaching a needle 
Namestitev igle
What NovoMix 30 is and what it is used for 
Kaj je zdravilo NovoMix 30 in za kaj ga uporabljamo
What you need to know before you use NovoMix 70 
Kaj morate vedeti, preden boste uporabili zdravilo NovoMix 70
Serious allergic reactions to NovoMix 70 or one of its ingredients (called a systemic allergic reaction) is a very rare side effect, but it can potentially be life-threatening. 
Resna alergijska reakcija na zdravilo NovoMix 70 ali katero od njegovih sestavin (to imenujemo sistemska alergijska reakcija) je zelo redek, a potencialno smrtno nevaren neželeni učinek.
Since NovoMix 70 should be administered in immediate relation to a meal, the rapid onset of action should be considered in patients with concomitant diseases or treatment where a delayed absorption of food might be expected. 
Ker je treba zdravilo NovoMix 70 aplicirati neposredno ob obroku, je treba pri bolnikih s sočasnimi boleznimi ali zdravljenjem, pri katerih lahko pričakujemo upočasnjeno absorpcijo hrane, upoštevati hiter začetek delovanja zdravila .
The influence of different injection sites on the absorption of NovoMix 30 has not been investigated. 
Vpliv različnih mest injiciranja na absorpcijo zdravila NovoMix 30 ni raziskan.
Pack sizes of 5 and 10 cartridges. 
Pakiranja s 5 in 10 vložki.
• Drink alcohol (see Drinking alcohol and taking NovoMix 70 in section 2). 
• če pijete alkohol (glejte poglavje 2, podpoglavje Zdravilo NovoMix 70 skupaj z alkoholom).
Before your first injection with a new FlexPen, you must resuspend the insulin: Roll the pen between your palms 10 times - it is important that the pen is kept horizontal (level with the ground). 
Injekcijski peresnik 10-krat zavrtite med dlanmi - pomembno je, da ga držite vodoravno (vzporedno s tlemi).
Serious allergic reactions to NovoMix 50 or one of its ingredients (called a systemic allergic reaction) is a very rare side effect, but it can potentially be life-threatening. 
Resna alergijska reakcija na zdravilo NovoMix 50 ali katero od njegovih sestavin (to imenujemo sistemska alergijska reakcija) je zelo redek, a potencialno smrtno nevaren neželeni učinek.
What NovoMix 30 is and what it is used for What you need to know before you use NovoMix 30 How to use NovoMix 30 
Kaj je zdravilo NovoMix 30 in za kaj ga uporabljamo Kaj morate vedeti, preden boste uporabili zdravilo NovoMix 30 Kako uporabljati zdravilo NovoMix 30
However, the NovoMix 70 dose may need to be adjusted. 
Lahko pa je potrebna prilagoditev odmerka zdravila NovoMix 70.
NovoMix 50 is generally taken immediately before a meal. 
Zdravilo NovoMix 50 se praviloma uporabi tik pred obrokom.
• Drink alcohol (see Drinking alcohol and taking NovoMix 50 in section 2). 
• če pijete alkohol (glejte poglavje 2, podpoglavje Zdravilo NovoMix 50 skupaj z alkoholom).
However, the NovoMix 50 dose may need to be adjusted. 
Lahko pa je potrebna prilagoditev odmerka zdravila NovoMix 50.
Serious allergic reactions to NovoMix 30 or one of its ingredients (called a systemic allergic reaction) is a very rare side effect, but it can potentially be life-threatening. 
Resna alergijska reakcija na zdravilo NovoMix 30 ali katero od njegovih sestavin (to imenujemo sistemska alergijska reakcija) je zelo redek, a potencialno smrtno nevaren neželeni učinek.
On rare occasions, injection site reactions may require discontinuation of NovoMix 70. 
V redkih primerih je lahko zaradi reakcij na mestu injiciranja potrebna prekinitev uporabe zdravila NovoMix 70.
Other medicines and NovoMix 70 
Druga zdravila in zdravilo NovoMix 70
What you need to know before you use NovoMix 50 
Kaj morate vedeti, preden boste uporabili zdravilo NovoMix 50
On rare occasions, injection site reactions may require discontinuation of NovoMix 50. 
V redkih primerih je lahko zaradi reakcij na mestu injiciranja potrebna prekinitev uporabe zdravila NovoMix 50.
► If you are treated with NovoMix 70 Penfill and another insulin Penfill cartridge, you should use two insulin delivery systems, one for each type of insulin. 
► Če se zdravite z zdravilom NovoMix 70 Penfill in še drugim insulinom v vložkih Penfill, morate za vsako vrsto insulina uporabiti svoj sistem za dajanje insulina.
NovoMix 50 will start to lower your blood sugar 10-20 minutes after you inject it, the maximum effect occurs between 1 and 4 hours after the injection, and the effect lasts for up to 14-24 hours. 
Zdravilo NovoMix 50 začne sladkor v krvi zniževati v 10 do 20 minutah po injiciranju, doseže največji učinek v 1 do 4 urah po injiciranju in deluje med 14 in 24 ur.
What NovoMix 70 looks like and contents of the pack 
Izgled zdravila NovoMix 70 in vsebina pakiranja
How to use NovoMix 70 
Kako uporabljati zdravilo NovoMix 70
I Keeping the needle upwards, press the push-button all the way in. 
Z iglo obrnjeno navzgor pritisnite potisni gumb do konca.